| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |